Analysis | Metabolite Name | Measured Value | Units | Sample type | Gender |
---|---|---|---|---|---|
Reversed Phase NEGATIVE (Named metabolites) | serine | 841 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 1783 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 2292 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 3475 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 3521 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 3669 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 4054 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 4266 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 4303 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 4879 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 5133 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 5152 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 5186 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 5251 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 5271 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 5277 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 5339 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 5471 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 5559 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 5662 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 5686 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 5984 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6108 | Peak area normalized | chear plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6193 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6208 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6260 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6361 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6601 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6605 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6620 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6623 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6660 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6691 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6810 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6993 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 6995 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7024 | Peak area normalized | red cross plasma | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7191 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7281 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7296 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7343 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7382 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7450 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7557 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7563 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7634 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7830 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7833 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7851 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7901 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7925 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7929 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7959 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7976 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7979 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 7996 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8022 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8052 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8056 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8057 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8077 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8089 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8102 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8104 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8290 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8297 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8317 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8390 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8432 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8433 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8461 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8495 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8577 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8585 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8587 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8617 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8628 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8690 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8695 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8720 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8743 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8775 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8791 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8798 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8802 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8815 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8822 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8872 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8901 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8908 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8932 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8946 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8972 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 8973 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9027 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9045 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9080 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9085 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9119 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9134 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9148 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9184 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9225 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9257 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9259 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9261 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9299 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9310 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9334 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9385 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9401 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9403 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9404 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9411 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9448 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9454 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9458 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9463 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9543 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9581 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9589 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9596 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9608 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9610 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9641 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9651 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9670 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9694 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9694 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9706 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9712 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9719 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9723 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9741 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9742 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9750 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9762 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9763 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9785 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9786 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9788 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9819 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9827 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9842 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9864 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9865 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9894 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9897 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9914 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9927 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9972 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 9978 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10010 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10020 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10031 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10062 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10118 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10155 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10174 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10185 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10195 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10220 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10225 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10227 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10251 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10267 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10274 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10297 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10298 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10306 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10310 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10325 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10340 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10353 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10355 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10357 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10364 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10369 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10393 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10397 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10407 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10417 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10419 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10428 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10445 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10449 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10459 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10460 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10463 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10474 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10476 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10483 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10483 | Peak area normalized | Sample | female |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10488 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10502 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10539 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10557 | Peak area normalized | master pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10563 | Peak area normalized | batch pool | - |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10563 | Peak area normalized | Sample | male |
Reversed Phase NEGATIVE (Named metabolites) | serine | 10568 | Peak area normalized | master pool | - |
Return to search page